Structure-based approach for the discovery of novel selective estrogen receptor modulators

C. Rosano, E. Stec-Martyna, R. Lappano, M. Maggiolini

Research output: Contribution to journalArticle

Abstract

In the last twenty years the efforts to design and optimize new drugs have been based on the three dimensional structure of the selected target proteins. In this regard, useful information has been achieved mainly by protein crystallography, which has recently turned from a low into a high-throughput process thanks to the improvement in robot technologies, automation procedure and the use of synchrotron radiation facilities [1-3]. This review examines the impact of Structure Based Drug Design (SBDD) on the discovery of ligands as the selective estrogen receptor modulators (SERMs) of the Estrogen Receptor (ER), which is involved in the regulation of several physiological and pathological processes.

Original languageEnglish
Pages (from-to)1188-1194
Number of pages7
JournalCurrent Medicinal Chemistry
Volume18
Issue number8
DOIs
Publication statusPublished - Mar 2011

    Fingerprint

Keywords

  • Estrogen
  • Estrogen receptor
  • Lasofoxifene
  • Raloxifene
  • Structure based drug design
  • Tamoxifen

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this